From: Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer
Dose in mg
Number of patients
Treatment duration (weeks)
DLT
200
3
No
400
700
1200
2000
Yes (patient 15)
9